SCHEMBL2806409

SCHEMBL2806409

COc1ccc(CNc2ncc3c(n2)-c2ccccc2C(c2ccc(Cl)cc2)C3)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 4/20 0.45
DYRK1A Q13627 3/20 0.45
DYRK1B Q9Y463 2/20 0.45
CLK1 P49759 1/20 0.45
CLK2 P49760 1/20 0.45
FGFR1 P11362 2/20 0.45
FGFR2 P21802 2/20 0.45
VNN1 O95497 1/20 0.45
HRH1 P35367 1/20 0.42
HRH4 Q9H3N8 1/20 0.42
CSF1R P07333 1/20 0.41
FGFR3 P22607 1/20 0.41
CCNA2 P20248 2/20 0.40
CDK2 P24941 2/20 0.40
CCNA1 P78396 2/20 0.40
AURKA O14965 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KDR P35968 1/20 0.40
EGFR P00533 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2807724 0.92 FGFR1 (0.45) CLK4DYRK1ADYRK1BCLK1CLK2
SCHEMBL2806102 0.91 FGFR1 (0.45) FGFR1FGFR2VNN1HRH1HRH4
SCHEMBL2803281 0.89 FGFR1 (0.54) FGFR1FGFR2VNN1CSF1RFGFR3
SCHEMBL2806030 0.89 FGFR1 (0.44) CLK4DYRK1AFGFR1FGFR2HRH1
SCHEMBL2805624 0.89 FGFR1 (0.44) CLK4DYRK1ADYRK1BCLK1CLK2
SCHEMBL2805361 0.85 FGFR1 (0.56) FGFR1FGFR2VNN1HRH1HRH4
SCHEMBL2806391 0.84 FGFR1 (0.51) FGFR1FGFR2CSF1RFGFR3CCNA2
SCHEMBL2806354 0.83 FGFR1 (0.47) CLK4DYRK1AFGFR1FGFR2VNN1
SCHEMBL2802111 0.83 FGFR1 (0.49) FGFR1FGFR2CSF1RFGFR3CCNA2
SCHEMBL2804590 0.82 FGFR1 (0.47) FGFR1FGFR2CSF1RFGFR3CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 CLK4 3350/4885DYRK1A 2130/4885DYRK1B 1958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.